Lactobacillus Species is More Cytotoxic to Human Bladder Cancer Cells Than Mycobacterium Bovis (Bacillus Calmette-Guerin)

This publication has 19 references indexed in Scilit:

• Chemopreventive Effect of Lactobacttlus rhamnosus on Growth of a Subcutaneously Implanted Bladder Cancer Cell Line in the Mouse
  Japanese Journal of Cancer Research, 2002
• BCG immunotherapy for superficial bladder cancer
  Journal of the Royal Society of Medicine, 2001
• Probiotic Spectra of Lactic Acid Bacteria (LAB)
  Critical Reviews in Food Science and Nutrition, 1999
• Demonstration of safety of probiotics — a review
  International Journal of Food Microbiology, 1998
• BACILLUS CALMETTE‐GUERIN (BCG) IMMUNOTHERAPY FOR BLADDER CANCER: REVIEW OF COMPLICATIONS AND THEIR TREATMENT
  Anz Journal of Surgery, 1998
• Effects on antitumor activity and cytokine production in the thoracic cavity by intrapleural administration of Lactobacillus casei in tumor-bearing mice
  Medical Microbiology and Immunology, 1996
• Miliary lung disease after intravesical bacillus Calmette-Guérin immunotherapy.
  Radiology, 1996
• Preventive Effect of a Lactobacillus casei Preparation on the Recurrence of Superficial Bladder Cancer in a Double-Blind Trial
  European Urology, 1995
• Effect of lc9018 combined with radiation therapy on carcinoma of the uterine cervix. A phase iii, multicenter, randomized, controlled study
  Cancer, 1993
• Antitumor Activity of Lactobacillus Casei (LC 9018) against Experimental Mouse Bladder Tumor (MBT-2)
  Journal of Urology, 1986